SAN DIEGO, Oct. 7, 2026 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a leading global provider of diagnostic solutions, has appointed Sanjeev Sharma, CFA, as Vice President, Investor Relations, effective September 28, 2026.
Mr. Sharma brings more than 20 years of experience across investor relations, corporate strategy and equity research at global organizations. Most recently, he served as Senior Director of Investor Relations at Teva Pharmaceuticals, where he closely partnered with senior leadership to communicate the company’s strategy and strengthen engagement with the investment community during a period of significant transformation. Previously, he spent more than a decade at Genpact in progressively senior roles across investor relations and business strategy. Earlier in his career, he spent nearly six years in sell-side equity research. Mr. Sharma holds a master’s degree in finance and is a Chartered Financial Analyst (CFA).
“We are pleased to welcome Sanjeev to QuidelOrtho,” said Micah Young, Chief Financial Officer of QuidelOrtho. “He brings a valuable combination of investor relations leadership, healthcare experience, financial expertise and capital markets perspective. Sanjeev’s experience partnering with executive teams and translating strategy and performance into a clear investor narrative will be especially valuable as we sharpen our communications and deepen our engagement with shareholders and analysts.”
Mr. Sharma added, “I am excited to join QuidelOrtho at this important stage in the company’s journey. QuidelOrtho plays a vital role in advancing healthcare around the world. I look forward to partnering with the leadership team to deepen engagement with the investment community and communicate the company’s strategic priorities and progress focused on long-term value creation.”
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Sanjeev Sharma
Vice President, Investor Relations
IR@QuidelOrtho.com
Media Contact:
Stephanie Kleewein
Senior Corporate Communication and PR Manager
media@QuidelOrtho.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-appoints-sanjeev-sharma-as-vice-president-of-investor-relations-302900416.html
SOURCE QuidelOrtho Corporation
